Approach for reliable evaluation of drug proteins interactions using surface plasmon resonance technology

Analytical Chemistry

Volumn 81, Issue 9, 2009, Pages 3551-3559

  Sandblad, Peter ^a   Arnell, Robert ^a   Samuelsson, Jörgen ^a   Fornstedt, Torgny ^a  

^a BMC Box 599 ^*  (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADSORPTION ENERGY DISTRIBUTION; ADSORPTION MODEL; BINDING COEFFICIENTS; BINDING PROPERTIES; CHIRAL DRUGS; CONCENTRATION RANGES; DRUG BINDING; DRUG CONCENTRATION; ENANTIOSELECTIVE; ENERGY DISTRIBUTIONS; EQUILIBRIUM DATA; HUMAN SERUM ALBUMINS; METHODOLOGICAL APPROACH; MODEL FITTING; MULTI-SITE; NEW TOOLS; PROTEIN DATA; PROTEIN INTERACTION; SITE BINDING; SURFACE PLASMON RESONANCE BIOSENSOR; TARGET PROTEINS; THROMBIN INHIBITORS; TRANSPORT PROTEINS; UNIMODAL;

ADSORPTION; BINDING ENERGY; BIOSENSORS; CHIRALITY; DIMETHYL SULFOXIDE; DRUG INTERACTIONS; DRUG PRODUCTS; ELECTRIC POWER DISTRIBUTION; ELECTRON WAVE TUBES; ENANTIOMERS; ENANTIOSELECTIVITY; ION BEAMS; PHYSICAL CHEMISTRY; PLASMONS; PROTEINS; SURFACE PLASMON RESONANCE;

BINDING SITES;

ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HUMAN SERUM ALBUMIN; MELAGATRAN; OROSOMUCOID; PLASMA PROTEIN; PROPRANOLOL; THROMBIN; WARFARIN;

ADSORPTION; ARTICLE; CALCULATION; CHIRALITY; DRUG BINDING SITE; DRUG PROTEIN BINDING; ENANTIOMER; ENANTIOSELECTIVITY; ENERGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MATHEMATICAL MODEL; MEDICAL TECHNOLOGY; SURFACE PLASMON RESONANCE;

DIMETHYL SULFOXIDE; HUMANS; OROSOMUCOID; PHARMACEUTICAL PREPARATIONS; PROPRANOLOL; PROTEIN BINDING; PROTEINS; REPRODUCIBILITY OF RESULTS; STEREOISOMERISM; SUBSTRATE SPECIFICITY; SURFACE PLASMON RESONANCE; WARFARIN;

EID: 66149133650     PISSN: 00032700     EISSN: None     Source Type: Journal    
DOI: 10.1021/ac900299p     Document Type: Article

References (42)

1. FDA, Development of New Stereoisomeric Drugs, 1992; http:// www.fda.gov/cder/guidance/stereo.htm; Jan 5, 1993.
2. Investigation of Chiral Active Substances. EMEA Clinical Guideline 3CC29A, EMEA guidelines, Apr 1994.
3. Frostell-Karlsson, Å.; Remaeus, A.; Roos, H.; Andersson, K.; Borg, P.; Hämäläinen, H.; Karlsson, R. J. Med. Chem. 2000, 43, 1986-1992.
4. Myszka, D. G.; Rich, R. L. Pharm. Sci. Technol. Today 2000, 3, 310-317.
5. Rich, R. L.; Day, Y. S. N.; Morton, T. A.; Myszka, D. G. Anal. Biochem. 2001, 296, 197-207.
6. Myszka, D. G. Anal. Biochem. 2004, 329, 316-323.
7. Arnell, R.; Ferraz, N.; Fornstedt, T. Anal. Chem. 2006, 78, 1682-1689.
8. Ahmad, A.; Ramakrishnan, A.; McLean, M. A.; Breau, A. P. Biosens. Bioelectron. 2003, 18, 399-404.
9. Hofstetter, O.; Hofstetter, H.; Wilchek, M.; Schurig, V.; Green, B. S. Nat. Biotechnol. 1999, 17, 371-374.
10. Corradini, R.; Feriotto, G.; Sforza, S.; Marchelli, R.; Gambari, R. J. Mol. Recognit. 2004, 17, 76-84.
11. Shahgaldian, P.; Hegner, M.; Pieles, U. J. Inclusion Phenom. Macrocyclic Chem. 2005, 53, 35-39.
12. Kima, W. S.; Lee, H. Y.; Kawai, T.; Kangc, H.-W.; Muramatsu, H.; Kim, I. H.; Park, K. M.; Chang, S. M.; Kim, J. M. Sens. Actuators, B 2008, 129, 126-133.
13. Day, Y. S. N.; Myszka, D. G. J. Pharm. Sci. 2003, 92, 333-343.
14. Abdiche, Y. N.; Myszka, D. G. Anal. Biochem. 2004, 328, 233-243.
15. Cheryl, L.; Baird, E. S. C.; Myszka, D. G. Anal. Biochem. 2002, 310, 93-99.
16. Cannon, M. J.; Myszka, D. G. Recent Res. Dev. Biophys. Biochem. 2003, 3, 333-344.
17. Rich, R. L.; Myszka, D. G. J. Mol. Recognit. 2005, 18, 431-478.
18. Rich, R. L.; Myszka, D. G. J. Mol. Recognit. 2005, 18, 1-39.
19. Rich, R. L.; Myszka, D. G. J. Mol. Recognit. 2007, 20, 300-366.
20. Fitos, I.; Visy, J.; Kardos, J. Chirality 2002, 14, 442-448.
21. Review article: Millot, M. C. J. Chromatogr. B 2003, 797, 131-159.
22. Xuan, H.; Hage, D. S. Anal. Biochem. 2005, 346, 300-310.
23. Mallik, R.; Xuan, H.; Guiochon, G.; Hage, D. S. Anal. Biochem. 2008, 376, 154-156.
24. Götmar, G.; Stanley, B.; Fornstedt, T.; Guiochon, G. Langmuir 2003, 19, 6950-6956.
25. Götmar, G.; Samuelsson, J.; Karlsson, A.; Fornstedt, T. J. Chromatogr. A 2007, 1156, 3-13.
26. Stanley, B.; Guiochon, G. J. Phys. Chem. 1993, 97, 8098-8104.
27. Guiochon, G.; Felinger, A.; Shirazi, D. G.; Katti, A. M. Fundamentals of Preparative and Nonlinear Chromatography. 2nd ed.; Academic Press: Boston, MA, 2006.
28. Jacobson, S. C.; Andersson, S.; Guiochon, G. Chirality 1993, 5, 513-515.
29. Gyimese-Forras, K.; Szaz, G.; Bathory, G.; Meszaros, G.; Gergely, A. Chirality 2003, 15, 377-381.
30. Dockal, M.; Chang, M.; Carter, D. C.; Ruker, F. Protein Sci. 2000, 9, 1455-1465.
31. Rahn, K. H.; Hawlina, A.; Kersting, F.; Planz, G. Naunyn Schmiedebergs Arch. Pharmacol. 1974, 286, 219-323.
32. Gustafsson, D.; Nyström, J. E.; Carlsson, S.; Bredberg, U.; Eriksson, U.; Gyzander, E.; Elg, M.; Antonsson, T.; Hoffmann, K. J.; Ungell, A. L.; Sörensen, H.; Någård, S.; Abrahamsson, A.; Bylund, R. Thromb. Res. 2001, 101, 171-181.
33. Miller, J. C.; Miller, J. N. Statistics for analytical chemistry, 3rd ed.; Ellis Horwood Ltd.: West Sussex, U.K., 1993.
34. Löfås, S.; Johansson, B.; Edström, Å.; Hansson, A.; Lindquist, G.; Müller Hillgren, R.-M.; Stigh, L. Biosens. Bioelectron. 1995, 10, 813-822.
35. Karlsson, R. J. Mol. Recognit. 1999, 12, 285-292.
36. Fornstedt, T.; Götmar, G.; Andersson, M.; Guiochon, G. J. Am. Chem. Soc. 1999, 121, 1164-1174.
37. Götmar, G.; Albareda, N. R.; Fornstedt, T. Anal. Chem. 2002, 74, 2950-2959.
38. Loun, B.; Hage, D. S. Anal. Chem. 1994, 66, 3814-3822.
39. Grønhøj Larsen, F.; Grønhøj Larsen, C.; Jakobsen, P.; Brodersen, R. Mol. Pharmacol. 1984, 27, 263-270.
40. Wong, A. K.; Hsia, J. C. Can. J. Biochem. Cell Biol. 1983, 61, 1114-1116.
41. Hanada, K.; Ohta, T.; Hirai, M.; Arai, M.; Ogata, H. J. Pharm. Sci. 2000, 89, 751-757.
42. Urien, S.; Brée, F.; Testa, B.; Tillement, J. P. Biochem. J. 1991, 280, 277-280.